Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$253K Buy
1,968
+14
+0.7% +$1.64K 0.05% 54
2026
Q1
$235K Hold
1,954
0.05% 55
2025
Q4
$212K Buy
+1,954
New +$183K 0.05% 58
2024
Q4
Sell
-1,964
Closed -$223K 60
2024
Q3
$223K Buy
1,964
+12
+0.6% +$1.43K 0.07% 47
2024
Q2
$242K Buy
1,952
+76
+4% +$9.79K 0.08% 46
2024
Q1
$248K Sell
1,876
-187
-9% -$23K 0.08% 47
2023
Q4
$225K Buy
2,063
+14
+0.7% +$1.45K 0.08% 43
2023
Q3
$211K Buy
2,049
+13
+0.6% +$1.4K 0.08% 41
2023
Q2
$235K Buy
2,036
+13
+0.6% +$1.48K 0.09% 36
2023
Q1
$215K Buy
+2,023
New +$218K 0.08% 38

Other funds holding MRK

Whitcomb & Hess's MRK Position: Q2 2026 in Review

Whitcomb & Hess increased its Merck (MRK) stake by 0.72% in Q2 2026, buying an estimated $1.64K and bringing the position to 1,968 shares worth $253K. The position accounts for 0.05% of the portfolio, ranked #54.

Whitcomb & Hess first reported a position in MRK in Q1 2023 and has held it in 10 quarters since. 2,296 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Whitcomb & Hess held 1,968 shares of Merck worth $253K as of Q2 2026.
  • Whitcomb & Hess bought 14 Merck shares in Q2 2026, an estimated $1.64K.
  • Merck made up 0.05% of Whitcomb & Hess's portfolio in Q2 2026, its #54 holding.
  • Whitcomb & Hess first reported a position in Merck in Q1 2023 and has held it in 10 quarters since.
  • 2,296 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Whitcomb & Hess's 13F filing for Q2 2026, filed 8 Jul 2026.